Treatment intensification in diffuse large B-Cell lymphoma: lessons for clinical trial design : Robert K. Hills
Reed Sternberg cell/lymphocyte rosettes in a bone marrow aspirate leading to the diagnosis of Hodgkin lymphoma
A rare case of worsening of Parkes Weber syndrome with development of POEMS syndrome : Images in haematology
Severe Epstein–Barr virus infection in primary immunodeficiency and the normal host : Review
Is it possible to cure childhood acute myeloid leukaemia without significant cardiotoxicity? : Review
Management of relapsed and refractory childhood acute promyelocytic leukaemia: recommendations from an international expert panel : Guideline
Peri-operative management of anticoagulation and antiplatelet therapy : Guideline
Chemotherapeutic intensity and survival differences in young patients with diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study : C. M. Melén et al
Renal disease related to Waldenström macroglobulinaemia: incidence, pathology and clinical outcomes : J. M. Vos et al
Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable : D. J. Landsburg et al
Pro-survival signal inhibition by CDK inhibitor dinaciclib in Chronic Lymphocytic Leukaemia : Y. Chen et al
Hodgkin lymphoma: a negative interim-PET cannot circumvent the need for end-of-treatment-PET evaluation : C. Mesguich et al
Progression of a solitary plasmacytoma to multiple myeloma. A population-based registry of the northern Netherlands : E. G. M de Waal et al
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) in the management of primary mediastinal B-cell lymphoma: a subgroup analysis of the UK NCRI R-CHOP 14 versus 21 trial : M. Gleeson et al
Re-evaluation of progenitor thresholds and expectations for haematopoietic recovery based on an analysis of 810 autologous transplants: Implications for quality assurance : Short Report
Predictors of anticoagulation quality in 15 834 patients performing patient self-management of oral anticoagulation with vitamin K antagonists in real-life practice: a survey of the International Self-Monitoring Association of Orally Anticoagulated Patients : C. Schaefer et al
Linkage disequilibrium amongst ITGA2B and ITGB3 gene variants in patients with Glanzmann thrombasthenia confirms that most disease-causing mutations are recent : X. Pillois and A. T. Nurden
Analysis of a cohort of 101 CDAII patients: description of 24 new molecular variants and genotype-phenotype correlations : P. Bianchi et al
Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease : S. M. Badawy et al
Sustained treatment of sickle cell mice with haptoglobin increases HO-1 and H-ferritin expression and decreases iron deposition in the kidney without improvement in kidney function : P. A. Shi et al
A rapid, inexpensive and disposable point-of-care blood test for sickle cell disease using novel, highly specific monoclonal antibodies : C. T. Quinn et al
Minimal tumour burden in haematological diseases: a step forward with quantitative assessment of Bence-Jones in nephelometry? : Correspondence
Rituximab-ABV(D) for patients with Nodular lymphocyte predominant Hodgkin lymphoma ineligible for radiation therapy : Correspondence
Analysis of RUNX1 rearrangements: insights into leukaemogenesis mechanisms : Correspondence
Biopreservation of RBCs for in vitro Plasmodium falciparum culture : Correspondence
Atypical haemolytic uraemic syndrome in a patient with sickle cell disease, successfully treated with eculizumab : Correspondence